Status:
WITHDRAWN
Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis
Lead Sponsor:
University of Zurich
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Objective(s): (i) To assess the effect of adjunctive topical steroids in the combined treatment with UVBnb and dithranol on the remission time after therapy till a relapse of psoriasis defined as 50%...
Detailed Description
(i) To assess the effect of adjunctive topical steroids in the combined treatment with UVBnb and dithranol on the remission time after therapy till a relapse of psoriasis defined as 50% loss of PASI (...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Moderate to severe psoriasis of the chronic-plaque and / or guttata type
- Exclusion criteria:
- Participation in a Goeckerman therapy regimen within 6 months previous to the present study
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01429870
Start Date
August 1 2011
End Date
August 1 2016
Last Update
July 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Dermatology Department
Zurich, Switzerland, 8091